Search research articles
Contact Us
Filters
Showing results (41-50 of 75) with videos related to
Page
of 8
Sort By:
Chest
|
November 14, 2007
Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension
Christopher J Boos, Deirdre A Lane, Manas Karpha, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
January 12, 2011
Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor
V J Karthikeyan, Andrew D Blann, Sabah Baghdadi, et al.
Journal of Hypertension
|
December 2, 2010
Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies
Vellore J Karthikeyan, Robin E Ferner, Sabah Baghdadi, et al.
American Journal of Hypertension
|
September 15, 2004
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Muzahir H Tayebjee, Sunil Nadar, Andrew D Blann, et al.
American Journal of Hypertension
|
March 31, 2005
Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension
Muzahir H Tayebjee, Ioannis Karalis, Sunil K Nadar, et al.
Angiology
|
May 24, 2011
Angiogenin and hemoxygenase in pregnancy: influence of hypertension
Velore J Karthikeyan, Gregory Y H Lip, Sabah Baghdadi, et al.
Angiology
|
May 11, 2011
Soluble Fas and Fas ligand in pregnancy: influence of hypertension
Velore J Karthikeyan, Gregory Y H Lip, Sabah Baghdadi, et al.
Journal of Hypertension
|
July 11, 2023
Antihypertensive treatment in people of very old age with frailty: time for a paradigm shift?
Eduard Shantsila, Gregory Y H Lip, Alena Shantsila, et al.
European Journal of Clinical Investigation
|
April 18, 2025
Prediction of major outcomes in patients with malignant hypertension using machine learning: A report from the West Birmingham malignant hypertension registry
Antonios A Argyris, Hironori Ishiguchi, Yang Chen, et al.
Journal of Hypertension
|
August 8, 2025
Long-term risk of adverse events in patients discharged alive after hospitalization for hypertensive crisis
Tommaso Bucci, Steven H M Lam, Antonios A Argyris, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 75) with videos related to
Sort By:
Page
of 8
Chest
|
November 14, 2007
Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension
Christopher J Boos, Deirdre A Lane, Manas Karpha, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
January 12, 2011
Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor
V J Karthikeyan, Andrew D Blann, Sabah Baghdadi, et al.
Journal of Hypertension
|
December 2, 2010
Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies
Vellore J Karthikeyan, Robin E Ferner, Sabah Baghdadi, et al.
American Journal of Hypertension
|
September 15, 2004
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Muzahir H Tayebjee, Sunil Nadar, Andrew D Blann, et al.
American Journal of Hypertension
|
March 31, 2005
Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension
Muzahir H Tayebjee, Ioannis Karalis, Sunil K Nadar, et al.
Angiology
|
May 24, 2011
Angiogenin and hemoxygenase in pregnancy: influence of hypertension
Velore J Karthikeyan, Gregory Y H Lip, Sabah Baghdadi, et al.
Angiology
|
May 11, 2011
Soluble Fas and Fas ligand in pregnancy: influence of hypertension
Velore J Karthikeyan, Gregory Y H Lip, Sabah Baghdadi, et al.
Journal of Hypertension
|
July 11, 2023
Antihypertensive treatment in people of very old age with frailty: time for a paradigm shift?
Eduard Shantsila, Gregory Y H Lip, Alena Shantsila, et al.
European Journal of Clinical Investigation
|
April 18, 2025
Prediction of major outcomes in patients with malignant hypertension using machine learning: A report from the West Birmingham malignant hypertension registry
Antonios A Argyris, Hironori Ishiguchi, Yang Chen, et al.
Journal of Hypertension
|
August 8, 2025
Long-term risk of adverse events in patients discharged alive after hospitalization for hypertensive crisis
Tommaso Bucci, Steven H M Lam, Antonios A Argyris, et al.
Page
of 8